இதழ் ஆஃப் தி அமெரிக்கன் மருந்தாளுநர்கள் சங்கம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study evaluates the difference in weight loss caused by two antidiabetic medications Patients with Type 2 diabetes who were prescribed SGLT2 inhibitors lost more weight than patients who received GLP-1 receptor agonists, according to a University at Buffalo-led study. The research, which sought to evaluate the difference in weight loss caused by the antidiabetic medications both of which work to control blood sugar levels found that among 72 patients, people using SGLT2 inhibitors experienced a median weight loss of more than 6 pounds, while those on GLP-1 receptor agonists lost a median of 2.5 pounds. The findings, published last month in the

United statesNicole paolini albaneseEmily hendersonJournal of the american pharmacists associationUniversity atSchool of pharmacyUniversity at buffaloAmerican pharmacists associationPaolini albaneseStudy lead authorClinical associate professorPharmacy practicePharmaceutical sciencesஒன்றுபட்டது மாநிலங்களில்எமிலி ஹென்டர்சன்இதழ் ஆஃப் தி அமெரிக்கன் மருந்தாளுநர்கள் சங்கம்